国际儿科学杂志
國際兒科學雜誌
국제인과학잡지
INTERNATIONAL JOURNAL OF PEDIATRICS
2012年
3期
323-324,封3
,共3页
高梅%曾华松%王信芳%何德根
高梅%曾華鬆%王信芳%何德根
고매%증화송%왕신방%하덕근
新生儿血小板减少性紫癜%丙种球蛋白%B细胞激活因子
新生兒血小闆減少性紫癜%丙種毬蛋白%B細胞激活因子
신생인혈소판감소성자전%병충구단백%B세포격활인자
Neonatal thrombocytopenic purpura%Gamma globulin%B cell activating factor
目的 探讨丙种球蛋白在新生儿血小板减少性紫癜(NTP)治疗中对血清B细胞激活因子(BAFF)的影响.方法 选取中山市中医院2009年10月至2011年9月收治的15例NTP患儿为治疗组,应用丙种球蛋白治疗,检测治疗组治疗前后及20例健康新生儿(对照组)血清BAFF的含量.结果 治疗组治疗前血清BAFF水平为(0.96+0.48) μg/L,对照组为(0.48±0.35) μg/L,两组比较差异有统计学意义(P<0.05);治疗组治疗后血清BAFF水平为(0.45±0.37) μg/L,与治疗前比较差异有统计学意义(P<0.05),与对照组比较差异无统计学意义.结论 丙种球蛋白治疗新生儿血小板减少性紫癜的免疫抑制可通过减少BAFF产生而发挥作用.
目的 探討丙種毬蛋白在新生兒血小闆減少性紫癜(NTP)治療中對血清B細胞激活因子(BAFF)的影響.方法 選取中山市中醫院2009年10月至2011年9月收治的15例NTP患兒為治療組,應用丙種毬蛋白治療,檢測治療組治療前後及20例健康新生兒(對照組)血清BAFF的含量.結果 治療組治療前血清BAFF水平為(0.96+0.48) μg/L,對照組為(0.48±0.35) μg/L,兩組比較差異有統計學意義(P<0.05);治療組治療後血清BAFF水平為(0.45±0.37) μg/L,與治療前比較差異有統計學意義(P<0.05),與對照組比較差異無統計學意義.結論 丙種毬蛋白治療新生兒血小闆減少性紫癜的免疫抑製可通過減少BAFF產生而髮揮作用.
목적 탐토병충구단백재신생인혈소판감소성자전(NTP)치료중대혈청B세포격활인자(BAFF)적영향.방법 선취중산시중의원2009년10월지2011년9월수치적15례NTP환인위치료조,응용병충구단백치료,검측치료조치료전후급20례건강신생인(대조조)혈청BAFF적함량.결과 치료조치료전혈청BAFF수평위(0.96+0.48) μg/L,대조조위(0.48±0.35) μg/L,량조비교차이유통계학의의(P<0.05);치료조치료후혈청BAFF수평위(0.45±0.37) μg/L,여치료전비교차이유통계학의의(P<0.05),여대조조비교차이무통계학의의.결론 병충구단백치료신생인혈소판감소성자전적면역억제가통과감소BAFF산생이발휘작용.
Objective To study the influence of gamma globulin to serum B cell activating factor (BAFF) in therapy of neonatal thrombocytopenic purpura.Methods Fifteen cases with neonatal thrombocytopenic purpura(treatment group) were treated with gamma globulin.Serum BAFF levels of treatment group before and after treatment and 20 healthy neonates(control group) were tested.Results Serum BAFF level of the treatment group before treatment was(0.96±0.48) μg/L,which was statistically significant compared with that of the control group[(0.48 ±0.35) μg/L](P <0.05).Serum BAFF level of treatment group after treatment was (0.45 ± 0.37) μg/L,which was statistically significant compared with that of before treatment (P < 0.05),but was not statistically significant compared with that of the control group.Conclusion Gamma globulin can play a role in the therapy of neonatal thrombocytopenic purpura by reducing the BAFF.